Jupiter Neurosciences, Inc. receives notice of non-compliance with Nasdaq listing standards

Jupiter Neurosciences has disclosed receipt of a deficiency notice from Nasdaq regarding failure to satisfy continued listing requirements. The company's ability to maintain its exchange listing is now under review, signaling potential liquidity or governance risks for shareholders.